Quantcast
Last updated on May 23, 2013 at 19:58 EDT
Species Recovery Programs May Spread Antibiotic Resistant

Species Recovery Programs May Spread Antibiotic Resistant Genes To Wild Populations

Public Library of Science Endangered brush-tail rock wallabies raised in captive breeding programs carry antibiotic resistance genes in their gut bacteria and may be able to transmit these genes into wild populations, according to research...

Latest Antibiotics Stories

2013-05-20 08:27:06

Solithromycin demonstrated enhanced anti-inflammatory response, in vitro CHAPEL HILL, N.C., May 20, 2013 /PRNewswire/ -- Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical medical needs in the treatment of bacterial infections, today announced that it presented data at the American Thoracic Society International Conference (ATS 2013) in Philadelphia demonstrating the antibacterial and enhanced...

2013-05-17 16:24:47

SAN DIEGO, May 17, 2013 /PRNewswire/ -- Sorrento Therapeutics, Inc. (OTCBB: SRNE; or STI) announced today that its Fast-Track Advanced Technology Small Business Technology Transfer Research (STTR) grant (#1R42AI098182-02) from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), supporting the development of novel human antibody therapeutics to combat Staphylococcus aureus (S. aureus or Staph) infections, including...

2013-05-16 12:30:20

SARASOTA, Fla., May 16, 2013 /PRNewswire/ -- Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today that a recent series of in vitro studies have provided new evidence that its novel class of antimicrobials, named bisphosphocins, function through a completely unique mechanism of action involving bacterial membrane depolarization, resulting in rapid direct bacterial killing. These studies expand on previously published experiments...

2013-05-13 16:27:40

- Cempra to Host Conference Call and Webcast at 4:30 p.m. EDT, Today, May 13, 2013 - CHAPEL HILL, N.C., May 13, 2013 /PRNewswire/ -- Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical needs in the treatment of bacterial infections, today announced the signing of an exclusive license and development agreement for solithromycin with Toyama Chemical Co., Ltd., a subsidiary of FUJIFILM Holdings...

2013-05-10 23:01:44

Drafted with assistance of Health Care Without Harm and Physicians for Social Responsibility, the resolution is intended to protect public health. San Francisco, CA (PRWEB) May 10, 2013 The University of California, San Francisco’s (UCSF) Academic Senate Coordinating Committee, the School of Pharmacy Faculty Council, and the School of Medicine Faculty Council unanimously approved a resolution in April to phase out the procurement of meat and poultry raised with non-therapeutic...

Antibiotics An Effective Treatment For Chronic Lower Back Pain
2013-05-10 17:01:38

Brett Smith for redOrbit.com – Your Universe Online A groundbreaking study from a well-renowned team of Danish researchers could bring unprecedented relief for sufferers of chronic back pain. According to the study, which appeared in the European Spine Journal, as much as 40 percent of chronic lower back pain is caused by bacteria. Treating these patients with antibiotics has resulted in a significant amount of relief and increased quality of life when compared to those patients...

2013-05-09 23:45:19

The website eProbiotics.com has recently published an informative article describing how probiotic’s and taking probiotic supplements have an effect on weight loss. Boston, MA (PRWEB) May 08, 2013 A new article from eProbiotics.com describes how probiotics and probiotic supplements are effectiveA new article from eProbiotics.com describes how probiotics and probiotic supplments are effectivly used for weight loss. Scientists have recently discovered that the hormones ghrelin and leptin,...

2013-05-08 13:38:30

Heiman Wertheim and Arjun Chandna from Oxford University and colleagues describe the launch and impact of VINARES, an initiative to strengthen antimicrobial stewardship in Viet Nam, which may be instructive for other countries struggling to address the threat of antimicrobial resistance. Antimicrobial resistance is increasingly recognized as a serious contemporary global health threat (with numerous calls for action from the international community), but while interventions to control...

2013-05-08 12:29:40

WASHINGTON, May 8, 2013 /PRNewswire-USNewswire/ -- The Pew Charitable Trusts today applauded Senators Kirsten Gillibrand (D-NY), Dianne Feinstein (D-CA), and Susan Collins (R-ME), for introducing the Antimicrobial Data Collection Act, which would require the U.S. Food and Drug Administration, or FDA, to report more information on the annual sales of antibiotics used among industrial farm animals. The bipartisan bill would also give the agency a deadline to finalize policies proposed last...

2013-05-08 11:38:12

Through the serendipity of science, researchers at the University of Pittsburgh have discovered a potential treatment for deadly, drug-resistant bacterial infections that uses the same approach that HIV uses to infect cells. The National Institutes of Health-supported discovery will be described in the June issue of the journal Antimicrobial Agents and Chemotherapy. It is especially promising in the development of a potential treatment for lung infections in people with cystic fibrosis....


Latest Antibiotics Reference Libraries

0_565be8ac4669df235cfa9eb09fa14a3d
2011-04-26 20:59:00

Staphylococcus epidermidis is one of thirty-three known species belonging to the genus Staphylococcus. It is part of our skin flora and can also be found in the mucous membranes and in animals. It is the most common species found in laboratory test due to contamination. It is not usually pathogenic; however, patients with a compromised immune system often risk infection. Infections can be both nosocomial and community acquired and are more of a threat to hospital patients. Hospitals carry...

0_9f897835bb09adc2a84fda23893d87f8
2011-04-15 13:50:01

Clostridium difficile, also known as "CDF/cdf", or "C. diff", is a Gram-positive bacteria of the genus Clostridium that causes severe diarrhea and other intestinal disease when competing bacteria in the gut flora are wiped out by antibiotics. They are anaerobic, spore-forming rods and is the most serious cause of antibiotic-associated diarrhea and potentially to pseudomembranous colitis. C. difficile bacteria naturally resides in the gut of a small percentage of the adult population. Others...

More Articles (2 articles) »